申请人:BENEVOLENTAI BIO LTD
公开号:WO2020128529A1
公开(公告)日:2020-06-25
The present invention relates to therapeutic compositions comprising a HSD11B1 inhibitor for use in the prevention, management and/or treatment of sarcopenia or a sarcopenic disease or disorder in individuals who are sensitive to insulin, and optionally following intermittent dosing.